Mengbo Hu

408 total citations
27 papers, 309 citations indexed

About

Mengbo Hu is a scholar working on Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mengbo Hu has authored 27 papers receiving a total of 309 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cancer Research, 7 papers in Molecular Biology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mengbo Hu's work include Cancer, Lipids, and Metabolism (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Mengbo Hu is often cited by papers focused on Cancer, Lipids, and Metabolism (7 papers), Cancer-related molecular mechanisms research (5 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Mengbo Hu collaborates with scholars based in China, United States and Australia. Mengbo Hu's co-authors include Qiang Ding, Jimeng Hu, Haowen Jiang, Tian Yang, Hua Xu, Wenhui Zhu, Xiaobo Wu, Peide Bai, Haowen Jiang and Limin Zhang and has published in prestigious journals such as Energy & Environmental Science, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Mengbo Hu

26 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengbo Hu China 11 119 109 77 65 55 27 309
Jimeng Hu China 12 227 1.9× 172 1.6× 109 1.4× 63 1.0× 45 0.8× 23 422
Carol Jones United States 11 120 1.0× 104 1.0× 122 1.6× 37 0.6× 36 0.7× 15 352
Peide Bai China 12 265 2.2× 237 2.2× 151 2.0× 104 1.6× 34 0.6× 31 499
Degang Ding China 11 176 1.5× 110 1.0× 62 0.8× 31 0.5× 56 1.0× 28 319
Baoxing Liu China 14 388 3.3× 299 2.7× 129 1.7× 96 1.5× 129 2.3× 51 687
Ran Zhuo China 8 173 1.5× 118 1.1× 70 0.9× 31 0.5× 94 1.7× 23 328
Haiqing He China 11 253 2.1× 161 1.5× 102 1.3× 43 0.7× 46 0.8× 20 359
Boxing Su China 11 191 1.6× 121 1.1× 111 1.4× 75 1.2× 56 1.0× 28 397
Tianshu Yang China 8 123 1.0× 48 0.4× 37 0.5× 46 0.7× 36 0.7× 20 311
Yongchang Lai China 13 277 2.3× 140 1.3× 260 3.4× 101 1.6× 40 0.7× 37 505

Countries citing papers authored by Mengbo Hu

Since Specialization
Citations

This map shows the geographic impact of Mengbo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengbo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengbo Hu more than expected).

Fields of papers citing papers by Mengbo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengbo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengbo Hu. The network helps show where Mengbo Hu may publish in the future.

Co-authorship network of co-authors of Mengbo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Mengbo Hu. A scholar is included among the top collaborators of Mengbo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengbo Hu. Mengbo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhaojun, Mengbo Hu, Dan Cheng, et al.. (2025). Breaking the H 2 O dissociation-OH desorption scaling relationship in alkaline hydrogen evolution by oxophilic single atom M 1 –Ru n electrocatalysts. Energy & Environmental Science. 18(9). 4302–4311. 7 indexed citations
2.
Wu, Fei, Jie Li, Mengbo Hu, et al.. (2025). HEC95468, a novel soluble guanylate cyclase stimulator, shows protection in the Dahl model of cardiorenal disorder. European Journal of Pharmacology. 1006. 178190–178190.
3.
Jiao, Yongjie, Xinan Chen, Fujun Wang, et al.. (2024). Enhancement structural and signaling microenvironment of artificial tumor extracellular matrix for enhanced drug screening. Journal of Tissue Engineering. 15. 1 indexed citations
4.
Zhou, Quan, Yuxi Ou, Xiyu Dai, et al.. (2023). Prevalence of tumour-infiltrating CD103+ cells identifies therapeutic-sensitive prostate cancer with poor clinical outcome. British Journal of Cancer. 128(8). 1466–1477. 6 indexed citations
5.
Liu, Xingxing, Yongjie Jiao, Mengbo Hu, et al.. (2022). A loofah-inspired scaffold with enhanced mimicking mechanics and tumor cells distribution for in vitro tumor cell culture platform. Biomaterials Advances. 135. 112672–112672. 4 indexed citations
6.
Bai, Peide, Tao Wang, Zhun Wu, et al.. (2021). Effect of Preoperative Double-J Ureteral Stenting before Flexible Ureterorenoscopy on Stone-free Rates and Complications. Current Medical Science. 41(1). 140–144. 6 indexed citations
7.
Wu, Xiaobo, Xingbo Long, Chen Yang, et al.. (2020). Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model. Journal of Cancer. 11(22). 6556–6564. 7 indexed citations
8.
Hu, Mengbo, et al.. (2019). First-time versus recurrent penoscrotal extramammary Paget's disease: Clinicopathological characteristics and risk factors in 164 Chinese male patients. Indian Journal of Dermatology Venereology and Leprology. 86(2). 134–134. 2 indexed citations
9.
10.
Yang, Tian, Xiaobo Wu, Jimeng Hu, et al.. (2018). Maternal High-Fat Diet Promotes the Development and Progression of Prostate Cancer in Transgenic Adenocarcinoma Mouse Prostate Offspring. Cellular Physiology and Biochemistry. 47(5). 1862–1870. 17 indexed citations
11.
Hu, Mengbo, Hua Xu, Wenhui Zhu, et al.. (2017). High-fat diet‑induced adipokine and cytokine alterations promote the progression of prostate cancer in�vivo and in�vitro. Oncology Letters. 15(2). 1607–1615. 24 indexed citations
12.
Hu, Jimeng, Wenhui Zhu, Bingbing Wei, et al.. (2016). Antitumoral action of icaritin in LNCaP prostate cancer cells by regulating PEA3/HER2/AR signaling. Anti-Cancer Drugs. 27(10). 944–952. 16 indexed citations
13.
14.
Hu, Jimeng, et al.. (2016). A novel anticancer agent icaritin inhibited proinflammatory cytokines in TRAMP mice. International Urology and Nephrology. 48(10). 1649–1655. 10 indexed citations
15.
Xu, Hua, Mengbo Hu, Peide Bai, et al.. (2015). Proinflammatory Cytokines in Prostate Cancer Development and Progression Promoted by High-Fat Diet. BioMed Research International. 2015. 1–7. 37 indexed citations
16.
Liu, Shenghua, Hu Zhang, Yishuo Wu, et al.. (2015). The Evaluation of the Risk Factors for Non-Muscle Invasive Bladder Cancer (NMIBC) Recurrence after Transurethral Resection (TURBt) in Chinese Population. PLoS ONE. 10(4). e0123617–e0123617. 28 indexed citations
17.
Liu, Shenghua, Tian Yang, Rong Na, et al.. (2015). The impact of female gender on bladder cancer-specific death risk after radical cystectomy: a meta-analysis of 27,912 patients. International Urology and Nephrology. 47(6). 951–958. 26 indexed citations
18.
Xu, Hua, Mengbo Hu, Peide Bai, et al.. (2014). Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?. International Urology and Nephrology. 46(12). 2327–2334. 12 indexed citations
19.
Hu, Mengbo, et al.. (2002). Interplays between genetic and environmental mechanisms trigger tumorigenic VEGF signalling in human HCC cell lines: pilot study. Biomedicine & Pharmacotherapy. 56(1). 50–55. 1 indexed citations
20.
Yu, Fang, et al.. (2001). Kinetics of tumorigenic vascular endothelial growth factor signalling and its significance in human hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy. 55(2). 102–110. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jimeng Hu Breakdown of academic impact, for papers by Carol Jones Breakdown of academic impact, for papers by Peide Bai Breakdown of academic impact, for papers by Degang Ding Breakdown of academic impact, for papers by Baoxing Liu Breakdown of academic impact, for papers by Ran Zhuo Breakdown of academic impact, for papers by Haiqing He Breakdown of academic impact, for papers by Boxing Su Breakdown of academic impact, for papers by Tianshu Yang Breakdown of academic impact, for papers by Yongchang Lai
Rankless by CCL
2026